The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study

Surgery for Obesity and Related Diseases

Volumn 13, Issue 3, 2017, Pages 491-500

  Stanford, Fatima Cody ^a,b   Alfaris, Nasreen ^a,b   Gomez, Gricelda ^b,c   Ricks, Elizabeth T ^d,e,f   Shukla, Alpana P ^d   Corey, Kathleen E ^a,b   Pratt, Janey S ^a,b   Pomp, Alfons ^d   Rubino, Francesco ^g   Aronne, Louis J ^e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f Paul L Foster School of Medicine   (United States)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Bariatric surgery; Inadequate weight loss; Obesity; Obesity co morbidities; Weight regain

Indexed keywords

TOPIRAMATE; ANTIOBESITY AGENT;

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; PHARMACEUTICAL CARE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROUX-EN-Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; WEIGHT GAIN; WEIGHT REDUCTION; CLINICAL TRIAL; DRUG EFFECTS; GASTRECTOMY; GASTRIC BYPASS SURGERY; HEALTHY LIFESTYLE; MIDDLE AGED; MORBID OBESITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CHRONIC CONDITIONS; YOUNG ADULT;

ADULT; AGED; ANTI-OBESITY AGENTS; BARIATRIC SURGERY; BODY MASS INDEX; COMBINED MODALITY THERAPY; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HEALTHY LIFESTYLE; HUMANS; MALE; MIDDLE AGED; MULTIPLE CHRONIC CONDITIONS; OBESITY, MORBID; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; WEIGHT GAIN; WEIGHT LOSS; YOUNG ADULT;

EID: 85008219337     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2016.10.018     Document Type: Article

References (46)

1. [1] Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311:8 (2014), 806–814.
2. [2] Guh, D.P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C.L., Anis, A.H., The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health, 9, 2009, 88.
3. [3] Buchwald, H., Avidor, Y., Braunwald, E., et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 292:14 (2004), 1724–1737.
4. [4] Chang, S.H., Stoll, C.R., Song, J., Varela, J.E., Eagon, C.J., Colditz, G.A., The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surg 149:3 (2014), 275–287.
5. [5] Sjostrom, L., Peltonen, M., Jacobson, P., et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311:22 (2014), 2297–2304.
6. [6] Gesquiere, I., Aron-Wisnewsky, J., Foulon, V., et al. Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients. Obes Surg 24:11 (2014), 1896–1903.
7. [7] Gumbs, A.A., Pomp, A., Gagner, M., Revisional bariatric surgery for inadequate weight loss. Obes Surg 17:9 (2007), 1137–1145.
8. [8] Meguid, M.M., Glade, M.J., Middleton, F.A., Weight regain after Roux-en-Y: A significant 20% complication related to PYY. Nutrition 24:9 (2008), 832–842.
9. [9] Coleman, K.J., Brookey, J., Gender and racial/ethnic background predict weight loss after Roux-en-Y gastric bypass independent of health and lifestyle behaviors. Obes Surg 24:10 (2014), 1729–1736.
10. [10] Coleman, K.J., Toussi, R., Fujioka, K., Do gastric bypass patient characteristics, behavior, and health differ depending upon how successful weight loss is defined?. Obes Surg 20:10 (2010), 1385–1392.
11. [11] Egberts, K., Brown, W.A., Brennan, L., O'Brien, P.E., Does exercise improve weight loss after bariatric surgery? A systematic review. Obes Surg 22:2 (2012), 335–341.
12. [12] Harvey, E.J., Arroyo, K., Korner, J., Inabnet, W.B., Hormone changes affecting energy homeostasis after metabolic surgery. Mt Sinai J Med 77:5 (2010), 446–465.
13. [13] Karmali, S., Brar, B., Shi, X., Sharma, A.M., de Gara, C., Birch, D.W., Weight recidivism post-bariatric surgery: A systematic review. Obes Surg 23:11 (2013), 1922–1933.
14. [14] Odom, J., Zalesin, K.C., Washington, T.L., et al. Behavioral predictors of weight regain after bariatric surgery. Obes Surg 20:3 (2010), 349–356.
15. [15] Pedersen, S.D., The role of hormonal factors in weight loss and recidivism after bariatric surgery. Gastroenterol Res Pract, 2013, 2013.
16. [16] Sala, P.C., Torrinhas, R.S., Giannella-Neto, D., Waitzberg, D.L., Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol Metab Syndr, 6, 2014, 87.
17. [17] Sarzynski, M.A., Jacobson, P., Rankinen, T., et al. Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes (Lond) 35:5 (2011), 676–683.
18. [18] Bastos, E.C., Barbosa, E.M., Soriano, G.M., dos Santos, E.A., Vasconcelos, S.M., Determinants of weight regain after bariatric surgery. Arq Bras Cir Dig 26:Suppl (2013), 26–32.
19. [19] DiGiorgi, M., Rosen, D.J., Choi, J.J., et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6:3 (2010), 249–253.
20. [20] Shah, M., Simha, V., Garg, A., Review: Long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 91:11 (2006), 4223–4231.
21. [21] Gawdat, K., Bariatric re-operations: Are they preventable?. Obes Surg 10:6 (2000), 525–529.
22. [22] Daigle, C.R., Aminian, A., Romero-Talamas, H., et al. Outcomes of a third bariatric procedure for inadequate weight loss. JSLS, 18(3), 2014, e2014 00117.
23. [23] Hallowell, P.T., Stellato, T.A., Yao, D.A., Robinson, A., Schuster, M.M., Graf, K.N., Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality?. Am J Surg 197:3 (2009), 391–396.
24. [24] Mann, J.P., Jakes, A.D., Hayden, J.D., Barth, J.H., Systematic review of definitions of failure in revisional bariatric surgery. Obes Surg 25:3 (2015), 571–574.
25. [25] Abu Dayyeh, B.K., Jirapinyo, P., Weitzner, Z., et al. Endoscopic sclerotherapy for the treatment of weight regain after Roux-en-Y gastric bypass: Outcomes, complications, and predictors of response in 575 procedures. Gastrointest Endosc 76:2 (2012), 275–282.
26. [26] Loewen, M., Barba, C., Endoscopic sclerotherapy for dilated gastrojejunostomy of failed gastric bypass. Surg Obes Relat Dis 4:4 (2008), 539–542 discussion 42–3.
27. [27] Pajecki, D., Halpern, A., Cercato, C., Mancini, M., de Cleva, R., Santo, M.A., Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery. Rev Col Bras Cir 40:3 (2013), 191–195.
28. [28] Zilberstein, B., Pajecki, D., Garcia de Brito, A.C., Gallafrio, S.T., Eshkenazy, R., Andrade, C.G., Topiramate after adjustable gastric banding in patients with binge eating and difficulty losing weight. Obes Surg 14:6 (2004), 802–805.
29. [29] Marchesini, S.D., Baretta, G.A., Cambi, M.P., Marchesini, J.B., Endoscopic plasma argon coagulation in treatment of weight regain after bariatric surgery: What does the patient think about this?. Arq Bras Cir Dig 27:Suppl (2015), 47–50.
30. [30] Cooper, T.C., Simmons, E.B., Webb, K., Burns, J.L., Kushner, R.F., Trends in weight regain following Roux-en-Y gastric bypass (RYGB) bariatric surgery. Obes Surg 25:8 (2015), 1474–1481.
31. [31] Mechanick, J.I., Youdim, A., Jones, D.B., et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 21:Suppl (2013), S1–27.
32. [32] Jester, L., Wittgrove, A.C., Clark, W., Adjunctive use of appetite suppressant medications for improved weight management in bariatric surgical patients. Obes Surg 6:5 (1996), 412–415.
33. [33] Schwartz, J., Suzo, A., Wehr, A.M., et al. Pharmacotherapy in conjunction with a diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: A retrospective review. Obes Surg 26:2 (2016), 452–458.
34. [34] Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
35. [35] Wing, R.R., Lang, W., Wadden, T.A., et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34:7 (2011), 1481–1486.
36. [36] American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013. Obesity (Silver Spring) 22:Suppl (2014), S5–39.
37. [37] Aronne, L.J., Wadden, T.A., Peterson, C., Winslow, D., Odeh, S., Gadde, K.M., Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity (Silver Spring) 21:11 (2013), 2163–2171.
38. [38] Padwal, R., Klarenbach, S., Wiebe, N., et al. Bariatric surgery: A systematic review and network meta-analysis of randomized trials. Obes Rev 12:8 (2011), 602–621.
39. [39] Blumenthal, S.R., Castro, V.M., Clements, C.C., et al. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry 71:8 (2014), 889–896.
40. [40] Rigler, S.K., Webb, M.J., Redford, L., Brown, E.F., Zhou, J., Wallace, D., Weight outcomes among antidepressant users in nursing facilities. J Am Geriatr Soc 49:1 (2001), 49–55.
41. [41] Schwartz, T.L., Nihalani, N., Jindal, S., Virk, S., Jones, N., Psychiatric medication-induced obesity: A review. Obes Rev 5:2 (2004), 115–121.
42. [42] Virk, S., Schwartz, T.L., Jindal, S., Nihalani, N., Jones, N., Psychiatric medication induced obesity: An aetiologic review. Obes Rev 5:3 (2004), 167–170.
43. [43] Alfaris, N., Wadden, T.A., Sarwer, D.B., et al. Effects of a 2-year behavioral weight loss intervention on sleep and mood in obese individuals treated in primary care practice. Obesity (Silver Spring) 23:3 (2015), 558–564.
44. [44] Faulconbridge, L.F., Wadden, T.A., Rubin, R.R., et al. One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity (Silver Spring) 20:4 (2012), 783–793.
45. [45] Rubin, R.R., Wadden, T.A., Bahnson, J.L., et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: The Look AHEAD Trial. Diabetes Care. 37:6 (2014), 1544–1553.
46. [46] Wadden, T.A., Vogt, R.A., Andersen, R.E., et al. Exercise in the treatment of obesity: Effects of four interventions on body composition, resting energy expenditure, appetite, and mood. J Consult Clin Psychol 65:2 (1997), 269–277.